Heng-Tong Choo

Heng-Tong CHOO is an accomplished executive with extensive experience in investment and management, currently serving as Executive Vice President at the Singapore Economic Development Board (EDB) since June 2018, overseeing key divisions such as EDBI and Innovation Economy. Previously, Heng-Tong held the position of Executive Vice President and Investment Head at EDBI Pte Ltd from January 2009 to June 2018, where contributions included participation in the Investment Committee and responsibilities in risk management and corporate governance. Heng-Tong's board and investment roles span various esteemed organizations, including Inviragen, Lonza Biologics, and GLOBALFOUNDRIES, and notable successes include founding investments in companies acquired by Takeda Pharma and Novo Nordisk. Educational achievements include an Advanced Management Programme from INSEAD, a Master of Arts in Biotechnology from Columbia University, and a Master of Engineering in Aeronautical Engineering from Imperial College London.